Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2010, for Cactus Ventures, Inc. (Note: The input metadata referenced "Actinium Pharmaceuticals," but the filing text explicitly identifies the registrant as Cactus Ventures, Inc.). The company is a Nevada corporation classified as a shell company and a smaller reporting company. It has no active operations, no employees, and is currently seeking a merger or acquisition target to become a reporting public company.
Key Financial Metrics
| Metric | Q1 2010 | Q1 2009 |
|---|---|---|
| Revenue | $0 | $0 |
| Net Loss | $(8,296) | $(5,313) |
| Loss Per Share | $(0.01) | $(0.01) |
| Cash and Equivalents | $1,198 | $2,194 |
| Total Assets | $1,198 | $2,122 |
| Total Liabilities | $105,786 | $98,414 |
| Shareholders' Deficit | $(104,588) | $(96,292) |
| Working Capital | $(31,574) | $(27,778) |
Debt and Liquidity: The company holds minimal cash ($1,198) against significant liabilities. Total liabilities include $73,014 in notes payable to related parties, $16,567 in accrued interest, and $11,545 in accounts payable. The company has no lines of credit other than potential advances from management.
Material Changes vs. Prior Period
- Increased Losses: Net loss increased by approximately 56% from $5,313 in Q1 2009 to $8,296 in Q1 2010.
- Rising Expenses: Total operating expenses rose from $3,878 to $6,537, driven primarily by an increase in professional fees (from $3,495 to $5,470) and other costs.
- Accrued Liabilities: Accrued legal fees increased significantly from $1,590 to $4,660. Accrued interest rose from $14,807 to $16,567.
- Cash Burn: Cash on hand decreased by $924 during the quarter due to operating losses, partially offset by $4,500 in new related-party notes.
Outlook, Risks, and Management Commentary
Going Concern: The filing explicitly states that the company's financial position raises substantial doubt about its ability to continue as a going concern. Continued operations depend entirely on the ability to raise additional funds and successfully implement a business plan (merger/acquisition).
Plan of Operations: Management anticipates expenses of approximately $20,000 for the next 12 months. The company relies on advances from its president to cover costs, though there is no assurance these will continue. The primary business activity is searching for a target company to merge with; no specific targets or negotiations are currently underway.
Risks:
- Failure to identify or negotiate a suitable business combination.
- Significant dilution to existing shareholders upon any future acquisition.
- Lack of capital to fund operations or acquisitions.
- Dependence on related-party financing.
Investor Verification Checklist
- Shell Status: Verify the company has no revenue, no employees, and no active business operations other than seeking a merger.
- Related Party Debt: Confirm the terms and repayment status of the $73,014 in notes payable to related parties and the $4,660 in accrued legal fees.
- Liquidity Crisis: Assess the risk of insolvency given the negative working capital of $(31,574) and cash balance of only $1,198.
- Management Funding: Verify the commitment of the president to provide the anticipated advances required to meet the $20,000 annual expense estimate.
- Share Count: Note the 11,155,008 shares outstanding, which may be subject to significant dilution in a future reverse merger.